All Content

How Systems and Plans Are Reframing Functional Recovery, Surgical Diversion, and Disability Risk Why MSK Is a Margin Lever in 2026 MSK is one of the largest cost centers  in both commercial and Medicare Advantage populations. Spine, orthopedics, pain, imaging, PT, opioids, and disability intersect in ways that directly influence total cost of care . The high-cost curve is not driven by: PT visit volume MRI utilization A single procedure The cost curve is driven by functional

How Health Systems and Payers Are Reframing GLP-1s, Obesity, Diabetes, and Cardiometabolic Risk Why Metabolic Is the Center of Financial Pressure in 2026 Metabolic disease is now the single largest driver  of long-term health spend in the U.S. Obesity, diabetes, hypertension, and cardiometabolic conditions account for a disproportionate share of avoidable admissions, cardiovascular events, MSK disability, and high-cost imaging and procedures. GLP-1s accelerated awareness — bu

Why now Behavioral health is no longer a sidecar: it’s a primary driver of system margin, network performance, and total-cost-of-care (TCOC). National health spend rose 7.5% in 2023 to ~$4.9T; Medicaid and private spend drove the increase, putting CFOs under pressure to bend cost curves without throttling access. Behavioral comorbidity multiplies medical spend (often 2–3×), especially in MSK and metabolic populations, making BH the keystone of 2026 contracting strategy. Cente

Behavioral Health, Metabolic Care, and MSK/Pain are traditionally contracted separately.Budgets, reporting, and negotiations sit in different silos. But in 2026, payers and health systems are evaluating these conditions together  because they drive the same total cost-of-care trajectory. Why This Matters The outcomes that determine cost curve slope are shared : Behavioral stability influences adherence and continuity Metabolic control shapes long-term chronic risk Functional

In the high-stakes arena of health tech, where innovation meets the rigid demands of reimbursement and risk management, outcomes data isn't just a buzzword—it's your golden ticket. For startups and established players alike, the path from pilot to full-scale contract hinges on demonstrating tangible value to health insurance executives in Medicare Advantage (MA) plans, commercial insurers, and employer-sponsored programs. These leaders, along with their tech and behavior chan

From Wellness Perk to Covered Benefit In 2025, wearables like Oura aren’t just fitness trackers—they’re revenue drivers for health plans and cost-savers for employers. With Medicare Advantage (MA) rebates topping $500 B in total payments and averaging around $2,255 per enrollee, plans are racing to bundle wearables into benefits that improve engagement and outcomes. Meanwhile, Oura’s $900 M raise and 5.5 M units sold prove enterprise buyers—payers, providers, and employers—ar

Unlocking the path from consumer-oriented wellness to reimbursable health-tech success. Introduction Most wellness and digital health startups begin as consumer platforms—focused on engagement, downloads, and growth metrics.But serious scale and enterprise value come when you transition into employer-paid or payer-covered offerings .That’s when your product moves from “nice to have” to “core benefit.” The commercial inflection point is no longer about user volume—it’s about p